Binding kinetics enable tumor-selective MAPK and growth suppression by a Type 1 RAF Inhibitor.
Desaunay M, Peters TL, Matenoglou E, Baars B, Gaire B, Orive-Ramos A, Ren L, Lyssikatos JP, Burkard MR, Dacus D, Sale MJ, Aaronson SA, McCormick F, Gavathiotis E, Gross SD, Poulikakos PI
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.